Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.

Autor: Gordan, Lucio N.1 (AUTHOR) lgordan@flcancer.com, Ray, David2 (AUTHOR), Ijioma, Stephen C.2 (AUTHOR), Dranitsaris, George3 (AUTHOR), Warner, Amanda1 (AUTHOR), Heritage, Trevor1 (AUTHOR), Fink, Matthew1 (AUTHOR), Wenk, David1 (AUTHOR), Chadwick, Paul1 (AUTHOR), Khrystolubova, Natasha1 (AUTHOR), Peles, Shachar1 (AUTHOR)
Zdroj: Current Oncology. Jan2024, Vol. 31 Issue 1, p501-510. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje